Transchem, a company in the Pharmaceuticals industry, reported revenue of ₹0.93 crore and net profit of ₹2.05 crore for the September 2026 quarter.
Transchem (BSE: TRANSCHEM) closed at ₹411.05 on 20 Nov 2026, up 451.9% over the past year. Its market capitalisation is ₹503 crore and it trades at 88.7 times earnings.
Transchem Ltd has transitioned from mushroom manufacturing and exports to financial services. After selling its non-operational Pune mushroom undertaking in 2020, it primarily earned through inter-corporate deposits and treasury investments.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.